R&D Improving treatment for high-risk cataract surgery Cataracts rank among the most prevalent age-related ailments.
Patients Developing bold medicines to preserve vision and transform t... My training as a clinical ophthalmologist and retinal surgeon led me to a career dedicated to developing better therapies for people suffering from debilitating eye diseases and the many co
Partner Content Partner Content Industry news with an exclusive interview by from Aerie Phar... Ophthalmic Drugs
Partner Content Partner Content Europe’s Leading Ophthalmic Conference is Just 1 week away Ophthalmic Drugs
Partner Content Partner Content SMi’s Europe’s Leading Ophthalmic Conference is only 2 weeks... Ophthalmic Drugs
Partner Content Partner Content SMi’s Europe’s Leading Ophthalmic Conference is only 3 weeks... Europe's Leading Ophthalmic Conference
News Angelini Pharma's R&D chief heads for the exit Dr Rafal Kaminski's near five-year tenure as chief scientific officer of Italy's Angelini Pharma will come to an end in the next couple of weeks.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.